Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program

Oncologist - United States
doi 10.1634/theoncologist.2015-0301
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Drug–drug Interaction Profile of Components of a Fixed Combination of Netupitant and Palonosetron: Review of Clinical Data

Journal of Oncology Pharmacy Practice
MedicineOncologyPharmacology
2015English

Pcn174 - Nepa, an Oral Fixed Combination of Netupitant and Palonosetron, Is a Cost-Effective Intervention for the Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) in Germany and Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Preventing Chemotherapy-Induced Nausea and Vomiting With Netupitant/Palonosetron, the First Fixed Combination Antiemetic: Current and Future Perspective

Future Oncology
MedicineCancer ResearchOncology
2019English

Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines
2011English

Postoperative Opioid Sparing With Injectable Hydroxypropyl-Β-Cyclodextrin-Diclofenac: Pooled Analysis of Data From Two Phase III Clinical Trials

Journal of Pain Research
AnesthesiologyPain Medicine
2016English

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Advances in Therapy
MedicinePharmacology
2020English

Using Phase II Data for the Analysis of Phase III Studies: An Application in Rare Diseases

Clinical Trials
MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy